EMRA Antibiotic Guide is a clinical reference app for emergency medicine physicians, providing antibiotic dosage and diagnostic recommendations via an annual subscription model.
Product velocity
Dormant
Daily rank 🇺🇸
#56
▲17Reference · grossing
Sentiment
2.7
205 reviews
Nemesis
Johns Hopkins Antibiotic Guide
The App DNA
What makes this app unique?
Clinicians hire this app to reduce cognitive load during high-pressure shifts, but the failure to provide current evidence-based updates undermines the primary job-to-be-done.
For Emergency medicine physicians and residents requiring quick, evidence-based antibiotic guidance during clinical shifts.
What does it look like?
Key features
Calculates patient-specific antibiotic dosages based on clinical inputs
Universal search interface for rapid navigation of antibiotic recommendations
How much does it cost?
Subscription-only model anchored at $9.99/year, requiring payment for all content access with no free trial.
Velocity
Dormant developmentopaqueShow more...
Development momentum is classified as zombie status due to the extreme infrequency of updates. The latest release occurred on March 5, 2026, following a significant period of inactivity dating back to May 2019. There is no evidence of a consistent release cadence or active feature development. The provided release notes are generic and offer no insight into product evolution.
Who built it?
Emergency Medicine Residents' Association
4 apps tracked · Reference
MobilEM
EMRA Peds Meds
EMRA PressorDexUser Sentiment
What do users think recently?
Review voice lately leans upset. Users appreciate quick reference tables provide helpful clinical information for daily practice and student study sessions, but report app crashes consistently when accessing specific clinical sections like bone and joint on android.
How are ratings & reviews evolving?
What users say, by theme
- Quick reference tables provide helpful clinical information for daily practice and student study sessions
- App crashes consistently when accessing specific clinical sections like bone and joint on Android
84 of 84 recent reviews analyzed · high confidence · Upset overall
Read the full review analysisUnlock 1 more frustration theme and 1 user request, each backed by review evidence.
Access the full report for freeCompetition
Competitive landscape for EMRA Antibiotic Guide
How's the Reference market?
The app holds the #80 Grossing position in the US Medical category, but the 2.43 Android rating indicates significant friction compared to the category average. This performance gap suggests that technical instability is actively suppressing monetization potential.
Read the market outlookThe rivals identified
By Unbound Medicine, Inc.
This is the direct market leader in the specialized antibiotic reference niche, maintaining high-frequency updates and a massive, loyal user base.
- Provides deep, evidence-based clinical decision support specifically for infectious disease management at the point of care.
- Leverages the Unbound Medicine platform to ensure rapid, consistent content updates across all mobile operating systems.
- Offers a specialized, curated database that functions as a professional-grade clinical tool rather than a general reference.
Unlock the head-to-head verdict: where this rival wins, and where it loses.
Access the full report for freeThe Analyst's Read
Key takeaways for EMRA Antibiotic Guide
Where is it heading?
The clinical reference market is consolidating around high-velocity, evidence-based tools that integrate into institutional workflows. EMRA's current maintenance-mode posture leaves it exposed to competitors that offer superior reliability and content freshness, so the app's survival depends on immediate technical remediation.
- Persistent crash reports on Android sections erode the daily active habit, which compounds the rating drag already visible on the platform.
- Stagnant clinical content updates despite annual billing drive user frustration, accelerating churn pressure toward free alternatives like Merck Manual.
The SWOT
- Emergency-specific workflow integration
- Evidence-based Choosing Wisely guideline support
- Professional association branding
- Wearable clinical support integration
- Electronic health record connectivity
- Residency program B2B partnerships
Next best moves
Rebuild subscription restoration flow because users cannot access paid content after device upgrades → reduce refund surge
+ 1 more prioritized moveThe counter-intuitive read
The app's subscription-only model is not a revenue driver but a churn accelerator…
Read the full takeFeature gaps
Real-time clinical decision support (available in Johns Hopkins Antibiotic Guide but absent here)
Since the last report: The app's competitive position has declined due to a sharp drop in user ratings and the emergence of specific, high-impact technical failures that prevent core functionality.
Bottom line
The app provides essential clinical utility but is failing to maintain basic technical reliability, so the PM must prioritize fixing subscription restoration and crash bugs to prevent total user churn.
Unlock 3 critical frictions, 3 market threats, 1 more prioritized move and the analyst’s take.
Access the full report for freeReport last updated